We scan new podcasts and send you the top 5 insights daily.
Proving the ROI of clinical AI can take years if based solely on patient outcomes. Instead, focus on early, measurable operational wins that are known proxies for better care. Track metrics like increased clinician capacity and higher patient engagement rates to prove the system's value and build momentum.
Technical metrics like "accuracy" are often the wrong measure for ML projects and can mismanage expectations. To achieve success, projects must be evaluated using business KPIs like profit, savings, or ROI. This aligns data science with business goals and reveals the true value of imperfect predictions.
A robust framework for measuring an AI agent's success requires a tiered approach. First, establish baseline quality (is it working correctly?). Then, measure user engagement (adoption, retention). Finally, connect these to top-line business impact (revenue, savings).
Demanding a direct, line-item ROI for foundational AI initiatives is like asking for the ROI on Wi-Fi—it's the wrong question. Instead of getting bogged down in impossible calculations, leaders should focus on measuring the business outcomes enabled by the technology, such as innovation speed or new product creation. Obsess on outcomes, not direct financial return.
Go beyond simple ROI to measure pilot success. Focus on: 1) Time to Value: delivering measurable outcomes within weeks. 2) Expansion Velocity: enabling the customer to achieve new business growth. 3) Engagement Depth: the customer actively pulling your product into new functions and creating a wishlist of use cases.
To gain physician trust, AI companies must move beyond proving their algorithm is accurate. The gold standard is large-scale clinical evidence demonstrating tangible improvements in patient outcomes, treatment rates, and decision-making speed.
The most tangible ROI for AI in healthcare today isn't in complex diagnostics, but in operational efficiency. AI scribes that free up doctors, intelligent call centers that triage patients correctly, and automated claim management are solving major bottlenecks and fighting burnout right now.
A traditional IT investment ROI model misses the true value of AI in pharma. A proper methodology must account for operational efficiencies (e.g., time saved in clinical trials, where each day costs millions) and intangible benefits like improved data quality, competitive advantage, and institutional learning.
Don't rely on traditional project milestones to gauge AI progress. Instead, measure success through granular unit economics and operational metrics. Metrics like 'cost per release' or 'cycle time per feature' provide immediate feedback on whether your strategic hypothesis is valid, enabling rapid iteration.
To prove AI's value, start with a simple spreadsheet for your team to track every use case. Log the tool, intent, and whether it saved time or money. This grassroots data collection reveals trends and quantifies savings, which then informs more intentional, top-down business goals.
Instead of fixating on lagging indicators like money saved, track leading indicators that signal behavioral shifts. For example, asking teams to rate their meeting preparedness on a 1-10 scale measures the effectiveness of AI-driven prep and predicts future performance gains.